摘要
目的:评估临床药师主导的慢性病管理在提高老年高血压患者药物了解程度方面的作用。方法:设计随机对照研究,纳入符合标准的老年高血压患者,出院时将患者随机分为对照组及干预组,临床药师对两组患者进行不同周期的随访,干预组前3个月每2周随访1次,后3个月每4周随访1次;对照组每3个月随访1次,随访时间均为6个月。统计两组在随访期内临床药师进行药物重整、用药教育、药物不良反应教育、生活方式教育及患者主动咨询的次数;分别在3、6个月时对两组患者的药物了解程度进行评分(1～3分,1分为完全了解,3分为不了解)。结果:最终分别纳入对照组和干预组患者32、25名,两组患者基线特征及药物了解程度评分[(1.59±0.49)、(1.6±0.5)]比较差异无统计学意义(P>0.05);对照组与干预组在第3个月时药物重整次数分别为(0.34±0.65)、(2.48±2.43)次(P<0.05),用药教育次数分别为(1.56±2.23)、(2.08±2.80)次,药物不良反应教育次数分别为(0.66±1.07)、(4.44±3.01)次(P<0.05),生活方式教育次数分别为(0.38±0.66)、(2.64±2.83)次(P<0.05),患者主动咨询次数分别为(0.41±1.10)、(0.44±0.92)次,药物了解程度评分分别为(2.00±0.67)、(1.32±0.56)分(P<0.05);第6个月时两组的上述6项数据分别为(0.09±0.39)、(1.88±1.76)次(P<0.05),(0.09±0.39)、(1.40±2.10)次(P<0.05),(0.13±0.42)、(1.76±1.56)次(P<0.05),(0.03±0.18)、(0.36±0.81)次(P<0.05),(0.06±0.35)、(0.16±0.47)次,(1.97±0.74)、(1.16±0.37)分(P<0.05),在患者药物了解程度评分上,临床药师干预组优于对照组。结论:临床药师主导的慢性病管理可提高老年高血压患者的药物了解程度。
OBJECTIVE：To evaluate the effects of clinical pharmacist-led chronic disease management on the improvement of drug understanding in elderly hypertensive patients. METHODS：In designed randomized controlled study,elderly hypertensive patients met inclusion criteria were randomly divided into control group and intervention group at discharge;clinical pharmacists followed up two groups during different periods. Intervention group was followed up once every 2 weeks in the first 3 months and once every 4 weeks in the latter 3 months. Control group was followed up once every 3 months,lasting for 6 months. The times of drug reorganization,medication education,ADR education,lifestyle education and patient counseling were counted in 2 groups during follow-up period. The drug understanding of patients was scored in 2 groups at 3 and 6 months（1-3 points,1 point was complete understanding,3 points meant no understanding）. RESULTS：Finally,32 and 25 patients were included in control group and intervention group,there was no statistical significance in baseline characteristics and the score of drug understanding [（1.59± 0.49）,（1.6 ± 0.5）] between 2 groups （P〉0.05）. In control group and intervention group,at 3 months,the times of drug reorganization were（0.34±0.65）and（2.48±2.43）（P〈0.05）;those of medication education were（1.56±2.23）and（2.08±2.80）;those of ADR education were（0.66±1.07）and（4.44±3.01）（P〈0.05）;those of lifestyle education were（0.38±0.66） and （2.64 ± 2.83）（P〈0.05）;those of patient counseling were （0.41 ± 1.10） and （0.44 ± 0.92）;those of score of drug understanding were （2.00 ± 0.67） and （1.32 ± 0.56）,respectively （P〈0.05）. At 6 months,above 6 indexes of 2 groups were （0.09±0.39）and（1.88±1.76）（P〈0.05）,（0.09±0.39）and（1.40±2.10）（P〈0.05）,（0.13±0.42）and（1.76±1.56）（P〈0.05）, （0.03±0.18）and（0.36±0.81）（P〈0.05）,（0.06±0.35）and（0.16±0.47）,（1.97±0
作者
武丹威
韩爽
施楠楠
张天婧
张威
甄健存
WU Danwei;HAN Shuang;SHI Nannan;ZHANG Tianjing;ZHANG Wei;ZHEN Jiancun(Dept.of Pharmacy,Beijing Jishuitan Hospital,Beijing 100035,China)
出处
《中国药房》
CAS
北大核心
2018年第23期3251-3254,共4页
China Pharmacy
基金
首都卫生发展科研专项项目(No.2016-2-2072)
关键词
慢性病管理
临床药师
老年高血压患者
药学服务
药物了解程度
Chronic disease management；Clinical pharmacist；Elderly hypertensive patient；Pharmaceutical care；Drug understanding
